The AIM2 total fluorescence intensity in CD4+ Trm cells in patients with SCLE and localized DLE was higher than in patients with psoriasis. The expression of AIM2 gene in skin CD4+ Trm cells can be a significant indicator to distinguish patients with ACLE from those with localized DLE and SCLE. The gene discussed is CD4; the disease is psoriasis.